Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
2.140
-0.120 (-5.31%)
Dec 5, 2025, 4:00 PM EST - Market closed
APUS Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2024 | FY 2023 | FY 2022 | FY 2021 |
| Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| Net Income | -5.16 | -1.39 | -0.78 | -0.67 | -1.03 |
| Stock-Based Compensation | 1.93 | - | 0.07 | 0.19 | 0.19 |
| Other Operating Activities | 0.08 | 0.12 | 0.04 | 0.03 | 0.01 |
| Change in Accounts Payable | 0.15 | 0.54 | 0.05 | -0 | 0 |
| Change in Other Net Operating Assets | -2.22 | 0 | -0.01 | 0 | -0 |
| Operating Cash Flow | -5.21 | -0.73 | -0.63 | -0.45 | -0.82 |
| Short-Term Debt Issued | - | 0.33 | 0.01 | 0.28 | - |
| Long-Term Debt Issued | - | - | - | - | 0.4 |
| Total Debt Issued | 0.34 | 0.33 | 0.01 | 0.28 | 0.4 |
| Short-Term Debt Repaid | - | - | -0.03 | - | - |
| Total Debt Repaid | -0.09 | - | -0.03 | - | - |
| Net Debt Issued (Repaid) | 0.25 | 0.33 | -0.02 | 0.28 | 0.4 |
| Issuance of Common Stock | 11.95 | - | 1.06 | - | - |
| Financing Cash Flow | 12.2 | 0.33 | 1.03 | 0.28 | 0.4 |
| Net Cash Flow | 6.96 | -0.41 | 0.4 | -0.17 | -0.42 |
| Levered Free Cash Flow | -3.39 | -0.29 | -0.35 | -0.2 | - |
| Unlevered Free Cash Flow | -3.33 | -0.22 | -0.32 | -0.18 | - |
| Change in Working Capital | -2.07 | 0.54 | 0.04 | -0 | 0 |
Source: S&P Capital IQ. Standard template.
Financial Sources.